Adaptive Biotechnologies Stock Quote ADPT - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.36

Bid

6.36

Ask

6.37

Volume

355,257

6.16 Day's Range 6.51

2.28 52 Week Range 6.70

Market Cap

938.606M

Previous Close

6.53

Open

6.48

Last Trade

6.365

Last Trade Time

11:49:50

Financial Volume

$ 2,252,414

VWAP

6.3402

Average Volume (3m)

1,179,224

Shares Outstanding

147,579,486

Dividend Yield

PE Ratio

-4.15

Earnings Per Share (EPS)

-1.53

Revenue

170.28M

Net Profit

-225.25M

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.adaptivebiotech.com

Headquarters

Olympia, Washington, USA

Founded

Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $6.53. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 2.28 to $ 6.70.

Adaptive Biotechnologies currently has 147,579,486 shares outstanding. The market capitalization of Adaptive Biotechnologies is $963.69 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -4.15.

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

SEATTLE, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

clonoSEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCL Coverage leverages new Medicare episode pricing established based on updated clonoSEQ gapfill rate...

Form 4 - Statement of changes in beneficial ownership of securities

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

SEATTLE, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.73	12.9662522202	5.63	6.575	5.29	1243711	6.00723999	CS
4	1.18	22.7799227799	5.18	6.7	4.27	1528737	5.41952725	CS
12	2.16	51.4285714286	4.2	6.7	3.981	1179224	5.07914165	CS
26	2.87	82.2349570201	3.49	6.7	2.99	1265836	4.48206892	CS
52	1.67	35.6076759062	4.69	6.7	2.28	1421586	4.03464395	CS
156	-19.98	-75.854214123	26.34	30.51	2.28	1290060	7.27056238	CS
260	-20.75	-76.5400221321	27.11	71.25	2.28	1139162	17.71751794	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CTNTCheetah Net Supply Chain Service Inc	$ 5.0408 (169.56%)	99.62M
ZJKZJK Industrial Company Ltd	$ 12.30 (94.01%)	13.4M
CTORCitius Oncology Inc	$ 1.7599 (72.54%)	90.74M
GWAVGreenwave Technology Solutions Inc	$ 0.5752 (57.59%)	281.33M
JANXJanux Therapeutics Inc	$ 62.385 (55.26%)	4.37M
REVBRevelation Biosciences Inc	$ 0.5734 (-39.64%)	2.55M
OMEXOdyssey Marine Exploration Inc	$ 0.4701 (-36.92%)	2.94M
GELSGelteq Ltd	$ 2.60 (-31.95%)	213.41k
XCURExicure Inc	$ 15.62 (-29.96%)	295.91k
SNTISenti Biosciences Inc	$ 7.1159 (-28.84%)	5.45M
GWAVGreenwave Technology Solutions Inc	$ 0.5758 (57.75%)	281.41M
SMCISuper Micro Computer Inc	$ 41.1027 (-2.14%)	146.77M
CTNTCheetah Net Supply Chain Service Inc	$ 5.04 (169.52%)	101.17M
CHRSCoherus BioSciences Inc	$ 1.985 (44.89%)	95.39M
CTORCitius Oncology Inc	$ 1.76 (72.55%)	90.93M